Altrinsic Global Advisors LLC Xenon Pharmaceuticals Inc. Transaction History

Altrinsic Global Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $4.27 Million - $5.63 Million	-170,000 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$8.08 - $17.57 $80,800 - $175,700	-10,000 Reduced 5.56%	170,000 $1.93 Million
Q2 2019 Aug 14, 2019	BUY	$8.51 - $10.75 $170,200 - $215,000	20,000 Added 12.5%	180,000 $1.78 Million
Q1 2019 May 14, 2019	BUY	$6.39 - $10.42 $63,900 - $104,200	10,000 Added 6.67%	160,000 $1.63 Million
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $168,300 - $378,600	30,000 Added 25.0%	150,000 $947,000
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $1.08 Million - $1.79 Million	120,000 New	120,000 $1.58 Million

211

70.2M

37.9K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.6B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.